Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Robson

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Lancet (London, England)|July 12, 1997
New BRCA2 mutation in an Ashkenazi Jewish family with breast and ovarian cancerM E Robson, K Offit
Histopathology|September 1, 1994
Dieulafoy's vascular malformation and primary pulmonary hypertension in a 10-year-old girlM E Robson, J McLennan
Oncology (Williston Park, N.Y.)|December 29, 2000
Screening for ovarian cancer: what we know, what we need to knowM L Hensley, M Castiel, M E Robson
Current Problems in Surgery|May 26, 2001
Hereditary breast cancerM E Robson, J Boyd, P I Borgen, et al.
Cancer|August 5, 2000
Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimens from BRCA1 heterozygotesR R Barakat, M G Federici, P E Saigo, et al.
Cancer|June 15, 1996
Acute pancreatitis associated with continuous infusion cytarabine therapy: a case reportC E McBride, R T Yavorski, F M Moses, et al.
Cancer Research|August 12, 1998
Molecular genetic characterization of BRCA1- and BRCA2-linked hereditary ovarian cancersE Rhei, F Bogomolniy, M G Federici, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 16, 2001
The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutationsJ M Satagopan, K Offit, W Foulkes, et al.
Gynecologic Oncology|March 27, 2001
Risk of endometrial carcinoma associated with BRCA mutationD A Levine, O Lin, R R Barakat, et al.
Clinical Genetics|June 9, 2011
Assessment of the prevalence of de novo mutations in the BRCA1 and BRCA2 genesL Zhang, M H Fleischut, K Kohut, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Lancet (London, England)|July 12, 1997
New BRCA2 mutation in an Ashkenazi Jewish family with breast and ovarian cancerM E Robson, K Offit
Histopathology|September 1, 1994
Dieulafoy's vascular malformation and primary pulmonary hypertension in a 10-year-old girlM E Robson, J McLennan
Oncology (Williston Park, N.Y.)|December 29, 2000
Screening for ovarian cancer: what we know, what we need to knowM L Hensley, M Castiel, M E Robson
Current Problems in Surgery|May 26, 2001
Hereditary breast cancerM E Robson, J Boyd, P I Borgen, et al.
Cancer|August 5, 2000
Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimens from BRCA1 heterozygotesR R Barakat, M G Federici, P E Saigo, et al.
Cancer|June 15, 1996
Acute pancreatitis associated with continuous infusion cytarabine therapy: a case reportC E McBride, R T Yavorski, F M Moses, et al.
Cancer Research|August 12, 1998
Molecular genetic characterization of BRCA1- and BRCA2-linked hereditary ovarian cancersE Rhei, F Bogomolniy, M G Federici, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 16, 2001
The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutationsJ M Satagopan, K Offit, W Foulkes, et al.
Gynecologic Oncology|March 27, 2001
Risk of endometrial carcinoma associated with BRCA mutationD A Levine, O Lin, R R Barakat, et al.
Clinical Genetics|June 9, 2011
Assessment of the prevalence of de novo mutations in the BRCA1 and BRCA2 genesL Zhang, M H Fleischut, K Kohut, et al.
Pageof 2